BioNexus Gene Lab (BGLC) Cash from Investing Activities (2018 - 2026)
BioNexus Gene Lab (BGLC) reported Cash from Investing Activities of -$13988.0 for Q1 2026, up 10.6% on a YoY basis from -$12647.7 in Q1 2025, and down 144.67% sequentially from -$5717.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Cash from Investing Activities (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of Cash from Investing Activities data on file, last reported at -$13988.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 10.6% year-over-year to -$13988.0; the trailing twelve-month figure through Mar 2026 stood at $946409.0 (up 137.25% YoY), and the FY2025 full-year result was $944751.0, up 125.91% from the prior year.
- Cash from Investing Activities eased to -$13988.0 in Q1 2026, from -$5717.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $994646.0 in Q3 2025 to a low of -$1.4 million in Q4 2023.
- A 5-year average of -$52690.3 and a median of -$13988.0 in 2026 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 2756.3% in 2023 and soared 2170.31% in 2024, its largest moves.
- Tracing BGLC's Cash from Investing Activities over 5 years: stood at -$49903.0 in 2022, then tumbled by 2756.3% to -$1.4 million in 2023, then soared by 138.9% to $554402.0 in 2024, then slumped by 101.03% to -$5717.0 in 2025, then tumbled by 144.67% to -$13988.0 in 2026.
- Business Quant data shows BGLC's Cash from Investing Activities at -$13988.0 in Q1 2026, -$5717.0 in Q4 2025, and $994646.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | -1.38 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | -170.50 Mn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | -1.98 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | -1.08 Bn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | -279.00 Mn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | -279.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | - |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 23.00 Mn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | -102.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -13,988.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,988.00 |
| Mar 31, 2026 | -13,988.00 |
| Dec 31, 2025 | -5,717.00 |
| Dec 31, 2025 | -5,717.00 |
| Sep 30, 2025 | 994,646.00 |
| Sep 30, 2025 | 994,646.00 |
| Jun 30, 2025 | -28,532.00 |
| Jun 30, 2025 | -28,532.00 |
| Mar 31, 2025 | -15,646.00 |
| Mar 31, 2025 | -15,646.00 |
| Dec 31, 2024 | 554,402.00 |
| Dec 31, 2024 | 554,402.00 |
| Sep 30, 2024 | -203,160.00 |
| Sep 30, 2024 | -203,160.00 |
| Jun 30, 2024 | 63,310.00 |
| Jun 30, 2024 | 63,310.00 |
| Mar 31, 2024 | 3,650.00 |
| Mar 31, 2024 | 3,650.00 |
| Dec 31, 2023 | -1.43 Mn |
| Dec 31, 2023 | -1.43 Mn |